Clinician Satisfaction With the VERABAND™

Part of paid clinical trials in La Jolla, California.

Sponsor
University of Michigan
Study ID
NCT06080464
Status
Recruiting

Conditions

  • Chronic Low-back Pain

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • VERABAND information — OTHER
    The device, VERABAND™, activity data reports (including a summary broken down by week) will be provided to treating clinicians prior to each patient's follow-up clinic visit.

Study Details

The VERABAND™ is a newly-developed, disposable, wearable activity monitor. The researchers will assess clinician satisfaction with the usability and likelihood of clinical adoption of the newly-developed, disposable, wearable activity monitor, across multiple clinical sites in the chronic low back pain (cLBP) population.

Key Dates

Start date
Jun 9, 2025
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Jun 30, 2027

Study Design

Enrollment
360 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: VERABAND information
    Consented patient participants will be given a VERABAND™ activity monitor during an initial clinic visit (baseline) and will then be tracked longitudinally after beginning a new pain treatment regime as part of their normal ongoing care. VERABAND™ activity data reports (including a summary broken down by week) will subsequently be provided to treating clinicians prior to each patient's follow-up clinic visit. The arm is all of the clinicians of the participants.

Primary Outcome Measure

Measure clinician satisfaction of the usability of the VERABAND™ using the System Usability Scale (SUS) [ Time Frame: approximately 7 weeks ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Altman Clinical and Translational Research InstituteLa JollaCalifornia92037
Yasmeen Esshaki
619-786-0375
Fadel Zeidan, PhD (PRINCIPAL_INVESTIGATOR)
University of Kansas Medical CenterKansas CityKansas66160
Miranda McMillan
913-588-7630
Andrea Chadwick, MD (PRINCIPAL_INVESTIGATOR)
University of MichiganAnn ArborMichigan48109
Kristi Pickup, MSW
734-764-4072
Daniel Whibley, PhD

Find similar trials in La Jolla, CA

Related Studies